Literature DB >> 20675025

From mainstream to marginal? Trends in the use of Chinese medicine in China from 1991 to 2004.

Lei Jin1.   

Abstract

In many Western societies, alternative healing options, including Chinese medicine, have started to move from the marginal to mainstream. In China, Chinese medicine has been an established component in the official health care system, but its relevance and effectiveness have often been challenged in a society committed to modernization. Despite abundant speculation, little research has established empirical facts regarding the use of Chinese medicine in China. This paper uses a longitudinal dataset to examine the trends from 1991 to 2004, and explore the extent to which changing population demographic and socioeconomic characteristics contributed to the observed trends. It finds that in the formal medical sector, the use of Chinese medicine has contracted, particularly in cities. Changing population demographic and socioeconomic characteristics cannot entirely account for the contraction. Rather, shifts in cultural values and structural changes in the health care system may have led to the observed decline. Copyright 2010 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2010        PMID: 20675025     DOI: 10.1016/j.socscimed.2010.06.019

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  9 in total

1.  What could 'integrative' medicine mean? Social science perspectives on contemporary Ayurveda.

Authors:  V Sujatha
Journal:  J Ayurveda Integr Med       Date:  2011-07

2.  Factors Affecting Definitions of and Approaches to Integrative Medicine: A Mixed Methods Study Examining China's Integrative Medicine Development.

Authors:  Weijun Zhang; Sonya E Pritzker; Ka-Kit Hui
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

3.  Is Traditional Chinese Medicine "Mainstream" in China? Trends in Traditional Chinese Medicine Health Resources and Their Utilization in Traditional Chinese Medicine Hospitals from 2004 to 2016.

Authors:  Xuefeng Shi; Dawei Zhu; Stephen Nicholas; Baolin Hong; Xiaowei Man; Ping He
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-31       Impact factor: 2.629

4.  Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China.

Authors:  Xiaofeng Jiang; Ping He; Dawei Zhu; Xuefeng Shi; Qingyue Meng
Journal:  Int J Equity Health       Date:  2020-12-10

5.  Strengthening of Traditional Chinese Medicine in the Health System Reform: Effect on Health Outcomes and Financial Protection.

Authors:  Ping He; Dawei Zhu; Xiaowei Man; Qian Bai; Lieyu Huang; Xuefeng Shi; Qingyue Meng
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-19       Impact factor: 2.629

6.  Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study.

Authors:  Zhengwei Huang; Xuefeng Shi; Stephen Nicholas; Elizabeth Maitland; Yong Yang; Weihan Zhao; Yong Ma; Yan Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-29       Impact factor: 2.629

7.  Medical Service Utilization and Direct Medical Cost of Stroke in Urban China.

Authors:  Dawei Zhu; Xuefeng Shi; Stephen Nicholas; Siyuan Chen; Ruoxi Ding; Lieyu Huang; Yong Ma; Ping He
Journal:  Int J Health Policy Manag       Date:  2022-03-01

8.  Integrating traditional chinese medicine services in community health centers: insights into utilization patterns in the pearl river region of china.

Authors:  Vincent C H Chung; Polly H X Ma; Harry H X Wang; Jia Ji Wang; Lau Chun Hong; Xiaolin Wei; Samuel Y S Wong; Jin Ling Tang; Sian M Griffiths
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-20       Impact factor: 2.629

9.  The association between the use of biomedical services and the holistic use of traditional East Asian medicine: a national survey of outpatients in South Korea.

Authors:  Jae-Mahn Shim; Yun-Suk Lee
Journal:  BMJ Open       Date:  2017-12-06       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.